Clinical decision support may improve CV health in mental illness – Consumer Health News
TUESDAY, March 8, 2022 (HealthDay News) — For patients with severe mental illness (SMI), a clinical decision support system (CDS) for primary care clinicians may slightly reduce the rate of increased risk total modifiable cardiovascular (CV), according to a study published online March 7 in Open JAMA Network.
Rebecca C. Rossom, MD, of the HealthPartners Institute in Minneapolis, and colleagues randomly assigned 76 primary care clinics in three Midwestern health care systems to receive or not receive a CDS system (42 intervention clinics; 34 clinics control) aimed at improving the CV health of the 8,937 patients with MMS. Patient-level change in total modifiable CV risk over 12 months was examined as the primary outcome measure.
The researchers found that, compared to control patients, patients in the intervention group had a 4% lower rate of increase in total modifiable CV risk (rate ratio [RR], 0.96). The intervention favored patients aged 18–29 or 50–59 (RR, 0.89 and 0.93, respectively) and black or white patients (RR, 0.93 and 0.96 , respectively). Men and women benefited from the intervention (RR, 0.96 and 0.95, respectively), as did patients with all subtypes of SMI (RR, 0.96, 0.94 and 0. 92 for bipolar disorder, schizoaffective disorder, and schizophrenia, respectively). No significant differences were observed between groups in individual modifiable risk factors.
“Our finding of a 4% relative decrease in modifiable CV risk in the intervention compared to control patients was modest but clinically significant, especially given the relatively low intensity of the intervention and the analysis in intention to treat,” the authors write.
One author disclosed financial ties to the biopharmaceutical industry.